207 related articles for article (PubMed ID: 36122543)
1. Muscle strength is a stronger prognostic factor than muscle mass in patients with gastrointestinal and hepatobiliary pancreatic cancers.
Nasu N; Yasui-Yamada S; Kagiya N; Takimoto M; Kurokawa Y; Tani-Suzuki Y; Kashihara H; Saito Y; Nishi M; Shimada M; Hamada Y
Nutrition; 2022; 103-104():111826. PubMed ID: 36122543
[TBL] [Abstract][Full Text] [Related]
2. Cross-sectional association of skeletal muscle mass and strength with dietary habits and physical activity among first-year university students in Japan: Results from the KEIJI-U study.
Kusakabe T; Arai H; Yamamoto Y; Nakao K; Akamatsu Y; Ishihara Y; Tagami T; Yasoda A; Satoh-Asahara N
Nutrition; 2024 Feb; 118():112265. PubMed ID: 37995554
[TBL] [Abstract][Full Text] [Related]
3. Effect of low skeletal muscle mass combined with low muscle strength to predict survival in patients with incurable cancer.
Calixto-Lima L; de Oliveira LC; Pimenta NG; de Albuquerque NMC; Chaves GV; Wiegert EVM
Clin Nutr ESPEN; 2022 Oct; 51():445-451. PubMed ID: 36184241
[TBL] [Abstract][Full Text] [Related]
4. Correlation between muscle mass and handgrip strength in digestive cancer patients undergoing chemotherapy.
Moreau J; Ordan MA; Barbe C; Mazza C; Perrier M; Botsen D; Brasseur M; Portefaix C; Renard Y; Tallière B; Bertin E; Hoeffel C; Bouché O
Cancer Med; 2019 Jul; 8(8):3677-3684. PubMed ID: 31115188
[TBL] [Abstract][Full Text] [Related]
5. Impact of volume status on sarcopenia in non-dialysis chronic kidney disease patients.
Kang SH; Kim JC; Cha RH; Han M; An WS; Kim SH; Do JY
Sci Rep; 2022 Dec; 12(1):22289. PubMed ID: 36566275
[TBL] [Abstract][Full Text] [Related]
6. Simple bedside tests of muscle strength and function correlate with computed tomography-skeletal muscle index for assessment of sarcopenia in cirrhosis.
Singh S; Taneja S; Roy A; Rathi S; De A; Verma N; Premkumar M; Duseja A; Dhiman RK; Singh V
Indian J Gastroenterol; 2023 Jun; 42(3):379-387. PubMed ID: 37222972
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors of sarcopenia in patients on maintenance hemodialysis: a retrospective cohort study.
Zhao Q; Zhu Y; Zhao X; Shi R; Lu T; Yu R; Wang D
BMC Musculoskelet Disord; 2024 May; 25(1):424. PubMed ID: 38822297
[TBL] [Abstract][Full Text] [Related]
8. Utility of handgrip strength (HGS) and bioelectrical impedance analysis (BIA) in the diagnosis of sarcopenia in cirrhotic patients.
Luengpradidgun L; Chamroonkul N; Sripongpun P; Kaewdech A; Tanutit P; Ina N; Piratvisuth T
BMC Gastroenterol; 2022 Mar; 22(1):159. PubMed ID: 35354434
[TBL] [Abstract][Full Text] [Related]
9. Normative cutoffs of muscle mass, muscle strength, and frailty for healthy Indian population.
Singh SA; Madan K; Prabhudesai AA; Agarwal AR; Rastogi R; Bhargava R; Kriplani P; Pampaniya H; Gupta S; Indrayan A
Indian J Gastroenterol; 2022 Dec; 41(6):591-598. PubMed ID: 36602720
[TBL] [Abstract][Full Text] [Related]
10. European Working Group on Sarcopenia in Older People (EWGSOP2) Criteria With Population-Based Skeletal Muscle Index Best Predicts Mortality in Asians With Cirrhosis.
Anand A; Mohta S; Agarwal S; Sharma S; Gopi S; Gunjan D; Madhusudhan KS; Singh N; Saraya A
J Clin Exp Hepatol; 2022; 12(1):52-60. PubMed ID: 35068785
[TBL] [Abstract][Full Text] [Related]
11. Dose-response relationships of sarcopenia parameters with incident disability and mortality in older Japanese adults.
Seino S; Kitamura A; Abe T; Taniguchi Y; Murayama H; Amano H; Nishi M; Nofuji Y; Yokoyama Y; Narita M; Shinkai S; Fujiwara Y
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):932-944. PubMed ID: 35212170
[TBL] [Abstract][Full Text] [Related]
12. Phase angle as a marker for muscle abnormalities and function in patients with colorectal cancer.
Souza NC; Avesani CM; Prado CM; Martucci RB; Rodrigues VD; de Pinho NB; Heymsfield SB; Gonzalez MC
Clin Nutr; 2021 Jul; 40(7):4799-4806. PubMed ID: 34271241
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia, Low Handgrip Strength, and Low Absolute Muscle Mass Predict Long-Term Mortality in Older Hospitalized Patients: An Observational Inception Cohort Study.
Scheerman K; Meskers CGM; Verlaan S; Maier AB
J Am Med Dir Assoc; 2021 Apr; 22(4):816-820.e2. PubMed ID: 33453174
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract][Full Text] [Related]
15. Association of physical activity with sarcopenia evaluated based on muscle mass and strength in older adults: 2008-2011 and 2014 - 2018 Korea National Health and Nutrition Examination Surveys.
Seo JH; Lee Y
BMC Geriatr; 2022 Mar; 22(1):217. PubMed ID: 35296249
[TBL] [Abstract][Full Text] [Related]
16. A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer.
Fu X; Tian Z; Wen S; Sun H; Thapa S; Xiong H; Liu H; Li L; Yu S
Nutrition; 2021 Feb; 82():111032. PubMed ID: 33172686
[TBL] [Abstract][Full Text] [Related]
17. Handgrip strength asymmetry as a new biomarker for sarcopenia and individual sarcopenia signatures.
Pratt J; Pessanha L; Narici M; Boreham C; De Vito G
Aging Clin Exp Res; 2023 Nov; 35(11):2563-2571. PubMed ID: 37658983
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Sarcopenia and Dynapenia and Related Clinical Outcomes in Patients with Type 1 Diabetes Mellitus.
Andreo-López MC; Zarco-Martín MT; Contreras-Bolívar V; Fernández-Soto ML
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068772
[TBL] [Abstract][Full Text] [Related]
19. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of Cutoff Value for Reduced Muscle Mass for GLIM Criteria in Patients with Gastrointestinal and Hepatobiliary-Pancreatic Cancers.
Takimoto M; Yasui-Yamada S; Nasu N; Kagiya N; Aotani N; Kurokawa Y; Tani-Suzuki Y; Kashihara H; Saito Y; Nishi M; Shimada M; Hamada Y
Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
